Do not blame the doctor for dengue

Published: 30 Jan 2015

 

 

The Federation of Private Medical Practitioners’ Associations, Malaysia (FPMPAM) would like to issue the following comments in response to the comments from the Malaysian heath minister on Jan 28, 2015 that private doctors fail to detect symptoms of dengue early.

Our members in general practitioner (GP) and family clinics have noted increasing number of dengue cases presenting with differing clinical patterns since the year 2000. Our doctors have been on unrelenting high alert for dengue cases since the year 2000.

It should be clearly stated that existing commercially available test kits cannot confirm the diagnosis of dengue in the early stages of the disease. What is most important is a high index of suspicion for all cases and the proper use of the test at the appropriate time.

This decision is best left to the attending doctor, to advise on adequate fluid consumption, monitor the patient regularly for danger signs and to refer problematic cases with potential complications to hospitals for further management. This has been the standard operating procedure recommended by the Health Ministry.

It is thus not correct that private primary care doctors cannot diagnose dengue in more than 99 percent of cases as was reported.

The alternative is to direct private doctors to send all cases of clinically suspected dengue i.e., virtually all cases with febrile illness to the public hospitals for further screening and management. This will mean crippling the already overloaded hospital facilities.

The majority of dengue cases do not need hospital care. We would like to emphasise that our private GPs are adequately trained and equipped to diagnose and manage such cases of dengue and should be appreciated for their effort to manage this disease at the primary care level.

DR STEVEN CHOW is president of the Federation of Private Medical Practitioners’ Associations, Malaysia (FPMPAM).

 

 

Originally published in malaysiakini.com
http://www.malaysiakini.com/letters/287855

 

Go Back

 

Events

30 Aug--1 Sept 2024
6th FPMPAM ASC
Details >>

 

16-17 Sept 2023
5th FPMPAM ASC
Details >>

30 Apr & 1 May 2023
FPMPAM / AMAM Joint ASM 2023
Details >>


Updates

27 Oct 2022
JA Assure Partners FPMPAM To Offer Professional Indemnity Insurance Platform To All Medical Professionals Of FPMPAM
Details >>

 

12 Oct 2022
Covid Fight: Private docs played key role
Details >>

 

17 Nov 2020
BIOLOGIC ADVISORY GROUP MY: Consensus Guidelines in Usage of Biologics in Dermatology during Covid-19 Pandemic
Details >>

30 Jun 2020
MOH Circular - Quarantine Process for General Practitioners
Details >>

 

31 Jan 2020
Handbook of 2019-nCoV Pneumonia Control and Prevention
Details >>

 

31 Jan 2020
Edaran Kemaskini Guidelines on 2019 Novel Coronavirus Management in Malaysia
Details >>

 

12 Aug 2018
Implementation of Data Breach Notification
Details >>

25 April 2018
Guidelines on Continuing Professional Development (CPD) for Medical Practitioners In Malaysia
Download >>

8 Mar 2018
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>

 

Latest Newsletter


go to newsletter section

 

 

Resources / Links

Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>

 

Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>

 

Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>

 

National Pharmaceutical Regulatory Agency
Click here >>

 

NPRA: Reporting medicinal problems
Click here >>

 

Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>

 

Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>

 

VALPROATE
Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>

 

NDST Report 2011
Click here >>

 

Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>

 

Report On Suspected Adverse Drug Reactions
Click here >>

 

MADRAC Newsletter Vol 26 Issue 2 / 2018
Read >>

 

MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>

BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>


Pharmacy Services Division: List of Adulterated Products
Read >>

 

Pharmacy Services Division: Press Releases
Read >>